Potential matrix metalloproteinase-9 inhibitor of aurone compound isolated from Sterculia quadrifida leaves: In-vitro and in-silico studies

In our previous study, aurone compound were found in the n-butanol fraction of Sterculia quadrifida leaves. The aurone compound (compound 1) had high cytotoxic activity in cell lines with IC50 values of 4.05, 12.53, 15.38, and 25.91 μg/mL in 4T1, MCF7, MDA-MB-435, T47D, respectively. In this study, we performed the MMP-9 enzyme inhibition test with FRET assay, and to deepen the mechanism of action of the compounds use molecular docking and molecular dynamics. The results showed that compound 1 had the MMP-9 enzyme inhibition of 91.23% and IC50 48.27%. Furthermore, molecular docking and molecular dynamic simulation suggest compound 1 interacts firmly and stably at the enzyme catalytic site. In conclusion, this study can provide important information on the development of herbal medicines that are potentially cancer drugs.

[1]  D. Dong,et al.  The role of TPS, CA125, CA15-3 and CEA in prediction of distant metastasis of breast cancer. , 2021, Clinica chimica acta; international journal of clinical chemistry.

[2]  Rohmad Yudi Utomo,et al.  Curcumin-like structure (CCA-1.1) induces permanent mitotic arrest (Senescence) on Triple-negative breast cancer (TNBC) cells, 4T1 , 2021, Research Journal of Pharmacy and Technology.

[3]  C. Nickson,et al.  The impact of the Covid-19 pandemic on breast cancer early detection and screening , 2021, Preventive Medicine.

[4]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[5]  Sterculia foetida Leaf Fraction Against Matrix Metalloproteinase-9 Protein and 4T1 Breast Cancer Cells: In-Vitro and In-Silico Studies , 2021, Tropical Journal of Natural Product Research.

[6]  Dar-Ren Chen,et al.  Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[7]  E. Taheri,et al.  Matrix metalloproteinase MMP1 and MMP9 genes expression in breast cancer tissue , 2020 .

[8]  Sinosh Skariyachan,et al.  Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugs , 2020, Computers in Biology and Medicine.

[9]  H. Wahab,et al.  Bioguided Fractionation of Local Plants against Matrix Metalloproteinase9 and Its Cytotoxicity against Breast Cancer Cell Models: In Silico and In Vitro Study , 2020, Molecules.

[10]  V. Vijayakumar,et al.  Molecular Docking Analysis of Triazole Analogues as Inhibitors of Human Neutrophil Elastase (HNE), Matrix Metalloproteinase (MMP 2 and MMP 9) and Tyrosinase , 2020 .

[11]  X. Bian,et al.  Triple-negative breast cancer molecular subtyping and treatment progress , 2020, Breast Cancer Research.

[12]  Muhammad Yusuf,et al.  Arylamide as Potential Selective Inhibitor for Matrix Metalloproteinase 9 (MMP9): Design, Synthesis, Biological Evaluation, and Molecular Modeling , 2019, J. Chem. Inf. Model..

[13]  Wirawan Adikusuma,et al.  Total Antioxidant and In-Vitro Cytotoxic of Abelmoschus Manihot (L.) Medik from palu of Central Sulawesi and Doxorubicin on 4T1 cells line and Vero Cells , 2019, Research Journal of Pharmacy and Technology.

[14]  T. Ikejima,et al.  Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion , 2019, Molecular and Cellular Biochemistry.

[15]  Tinghong Ye,et al.  Inhibition of Stat3 Signaling Pathway by Natural Product Pectolinarigenin Attenuates Breast Cancer Metastasis , 2019, Front. Pharmacol..

[16]  T. Hussain,et al.  Overexpression of matrix metalloproteinase‐9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling , 2019, Cell proliferation.

[17]  Juan Li,et al.  Herbacetin suppressed MMP9 mediated angiogenesis of malignant melanoma through blocking EGFR-ERK/AKT signaling pathway. , 2019, Biochimie.

[18]  Hao Huang,et al.  Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances , 2018, Sensors.

[19]  S. Banskota,et al.  Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis , 2018, Experimental & Molecular Medicine.

[20]  M. Raja,et al.  In Silico Molecular Docking Studies on the Chemical Constituents of Clerodendrum phlomidis for its Cytotoxic Potential against Breast Cancer Markers , 2018 .

[21]  M. X. Suresh,et al.  Computational Modeling of Novel Drug Targets ftsE and mpt83 for MDRTB and Molecular Docking of Selected Compounds from Medicinal Plants. , 2018 .

[22]  Z. Al-shehabi,et al.  Detecting the role of CCR7-CCL21/CCL19 axis in Breast Cancer Progression and lymph node Metastasis Incidence , 2018 .

[23]  C. Manasa,et al.  Evaluation of Anticancer Activity of Ethanolic and Ethylacetoacetate Extracts of Sweet Cherry Against Human Breast Cancer Cell Line MCF-7 , 2016 .

[24]  H. More,et al.  Inhibitory Effects of Successive Solvant Extracts of Barleria gibsoni Dalz. on the Proliferation of MDA MB 4355 (Human Breast Cancer) and Hep G2 (Liver Cancer Cell line) , 2015 .

[25]  C. Alisa,et al.  In Silico Geometry Optimization, Excited-State Properties of (2E)-N-Hydroxy-3-[3-(Phenylsulfamoyl) Phenyl] prop-2-Enamide (Belinostat) and its Molecular Docking Studies with Ebola Virus Glycoprotein , 2015 .